Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Youjun Huang
Institution:
Sanofi (France)
Observed institution:
Sanofi (France)
ORCID:
0009-0002-8185-6160
Observed ORCID:
0009-0002-8185-6160
OpenAlex ID:
A5139765692
High-dose vs standard-dose influenza vaccine in heart failure: the FLUNITY-HD pooled analysis
2026
·
Niklas Dyrby Johansen
, Daniel Modin
, et al.
·
European Heart Journal
·
2
Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2
2026
·
Caroline Espersen
, Niklas D Johansen
, et al.
·
The Lancet Healthy Longevity
·
1
Abstract 16691: High-Dose versus Standard-Dose Influenza Vaccine in Older Adults with Neurological and Cerebrovascular Disease: A Prespecified Analysis of the DANFLU-2 Trial
2026
·
Marat Yafasov
, Niklas D Johansen
, et al.
·
Circulation
Effectiveness of High-Dose vs. Standard-Dose Influenza Vaccine in Older Adults with Chronic Lung Disease: A Prespecified Analysis of the FLUNITY-HD Study
2026
·
Lisa Steen Duus
, Niklas Dyrby Johansen
, et al.
·
European Respiratory Journal
Safety and immunogenicity of concomitant quadrivalent meningococcus ACYW-TT and meningococcus group B vaccines
2026
·
Monica A. McArthur
, Adam Finn
, et al.
·
npj Vaccines
PDF
Positive predictive value of respiratory infection diagnoses in the Danish National Patient Registry: A post hoc validation analysis of the DANFLU-1 trial
2026
·
Jacob Christensen
, Niklas Dyrby Johansen
, et al.
·
International Journal of Infectious Diseases
PDF
Show more works
View as search
Works count:
6
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type
